Sun Pharma shares plunge over 12% on whistleblower complaint2 min read 18 Jan 2019, 11:12 AM IST
Sun Pharma distributor Aditya Medisales allegedly had transactions worth more than ₹5,800 crore with Suraksha Realty
Suraksha Realty is controlled by Dilip Shanghvi's partner in the company, Sudhir Valia.
Mumbai: A whistleblower complaint of governance concerns led to a steep fall in the shares of Sun Pharmaceuticals Industries Ltd on Friday. Sun Pharma share prices plunged 12.12% to ₹375.4 during the day’s trading, lowest since February 2013, before closing at ₹390.75, after a media report of a complaint by the unnamed whistleblower to the Securities and Exchange Board of India (Sebi) raised concerns on the drugmaker’s corporate governance.
Select your Category